Geri R Brown1, George W Lane, Bonnie J Whittington. 1. Department of Internal Medicine, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA. geri.brown@utsouthwestern.edu
Abstract
BACKGROUND: The present studies determined the role of LIGHT on organ-specific cytokine and effector molecules in acute graft-versus-host disease. METHODS: Cytokine and effector molecules were assessed by flow cytometry and quantitative PCR. RESULTS: More CD4+ spleen cells (SpC) expressing interferon-gamma (IFNgamma) and interleukin-2 were noted in SpC isolated from lethally irradiated bm12 X B6 F1 recipients of B6 donor SpC and T cell-depleted bone marrow cells and control Adv-betagal than in transplant (bone marrow transplantation (BMT)) recipients who had received Adv-LTbetaR-Ig or Adv-herpes simplex virus entry mediator (HVEM)-Ig. IFNgamma RNA levels from SpC, small intestines, and large intestines of control BMT recipients were significantly higher than those who had received Adv-HVEM-Ig. Granzyme B levels from SpC and small intestines of control BMT recipients were significantly higher than those that had received the Adv-LTbetaR-Ig. In contrast, BMT recipients of Adv-HVEM-Ig had lower granzyme A levels than controls in their large intestines. DISCUSSION: LIGHT inhibition differentially affects cytokines and effector molecules in SpC, small intestines, and large intestines, implicating different organ-specific pathways.
BACKGROUND: The present studies determined the role of LIGHT on organ-specific cytokine and effector molecules in acute graft-versus-host disease. METHODS: Cytokine and effector molecules were assessed by flow cytometry and quantitative PCR. RESULTS: More CD4+ spleen cells (SpC) expressing interferon-gamma (IFNgamma) and interleukin-2 were noted in SpC isolated from lethally irradiated bm12 X B6 F1 recipients of B6 donor SpC and T cell-depleted bone marrow cells and control Adv-betagal than in transplant (bone marrow transplantation (BMT)) recipients who had received Adv-LTbetaR-Ig or Adv-herpes simplex virus entry mediator (HVEM)-Ig. IFNgamma RNA levels from SpC, small intestines, and large intestines of control BMT recipients were significantly higher than those who had received Adv-HVEM-Ig. Granzyme B levels from SpC and small intestines of control BMT recipients were significantly higher than those that had received the Adv-LTbetaR-Ig. In contrast, BMT recipients of Adv-HVEM-Ig had lower granzyme A levels than controls in their large intestines. DISCUSSION: LIGHT inhibition differentially affects cytokines and effector molecules in SpC, small intestines, and large intestines, implicating different organ-specific pathways.
Authors: J Wang; T Chun; J C Lo; Q Wu; Y Wang; A Foster; K Roca; M Chen; K Tamada; L Chen; C R Wang; Y X Fu Journal: J Immunol Date: 2001-11-01 Impact factor: 5.422
Authors: J L Browning; I D Sizing; P Lawton; P R Bourdon; P D Rennert; G R Majeau; C M Ambrose; C Hession; K Miatkowski; D A Griffiths; A Ngam-ek; W Meier; C D Benjamin; P S Hochman Journal: J Immunol Date: 1997-10-01 Impact factor: 5.422
Authors: E D Thomas; R Storb; R A Clift; A Fefer; L Johnson; P E Neiman; K G Lerner; H Glucksberg; C D Buckner Journal: N Engl J Med Date: 1975-04-24 Impact factor: 91.245
Authors: H Körner; M Cook; D S Riminton; F A Lemckert; R M Hoek; B Ledermann; F Köntgen; B Fazekas de St Groth; J D Sedgwick Journal: Eur J Immunol Date: 1997-10 Impact factor: 5.532
Authors: M Tkachuk; S Bolliger; B Ryffel; G Pluschke; T A Banks; S Herren; R H Gisler; M H Kosco-Vilbois Journal: J Exp Med Date: 1998-02-16 Impact factor: 14.307
Authors: Pritesh Desai; Vikas Tahiliani; Tarun E Hutchinson; Farhad Dastmalchi; Jessica Stanfield; Georges Abboud; Paul G Thomas; Carl F Ware; Jianxun Song; Michael Croft; Shahram Salek-Ardakani Journal: J Immunol Date: 2018-03-07 Impact factor: 5.422